| Efficacy and safety of pembrolizumab or pembrolizumab plus chemotherapy vs chemotherapy alone for patients with first-line, advanced gastric cancer: the KEYNOTE-062 phase 3 … K Shitara, E Van Cutsem, YJ Bang, C Fuchs, L Wyrwicz, KW Lee, ... JAMA oncology 6 (10), 1571-1580, 2020 | 950 | 2020 |
| Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma Y Doki, JA Ajani, K Kato, J Xu, L Wyrwicz, S Motoyama, T Ogata, ... New England Journal of Medicine 386 (5), 449-462, 2022 | 767 | 2022 |
| The rising incidence of younger patients with colorectal cancer: questions about screening, biology, and treatment LC Connell, JM Mota, MI Braghiroli, PM Hoff Current treatment options in oncology 18, 1-20, 2017 | 246 | 2017 |
| Pembrolizumab with or without chemotherapy versus chemotherapy for advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma: The phase III KEYNOTE-062 study. J Tabernero, E Van Cutsem, YJ Bang, CS Fuchs, L Wyrwicz, KW Lee, ... Journal of Clinical Oncology 37 (18_suppl), LBA4007-LBA4007, 2019 | 201 | 2019 |
| Bevacizumab: overview of the literature MI Braghiroli, J Sabbaga, PM Hoff Expert review of anticancer therapy 12 (5), 567-580, 2012 | 124 | 2012 |
| Tratado de oncologia PMG HOFF Atheneu, 2013 | 109 | 2013 |
| Clinical features and outcomes of patients with colorectal cancers harboring NRAS mutations A Cercek, MI Braghiroli, JF Chou, JF Hechtman, N Kemeny, L Saltz, ... Clinical Cancer Research 23 (16), 4753-4760, 2017 | 97 | 2017 |
| Nivolumab (NIVO) plus ipilimumab (IPI) or NIVO plus chemotherapy (chemo) versus chemo as first-line (1L) treatment for advanced esophageal squamous cell carcinoma (ESCC): First … I Chau, Y Doki, JA Ajani, J Xu, L Wyrwicz, S Motoyama, T Ogata, ... Journal of Clinical Oncology 39 (18_suppl), LBA4001-LBA4001, 2021 | 94 | 2021 |
| Phase 2 trial of metformin combined with 5-fluorouracil in patients with refractory metastatic colorectal cancer VC Miranda, MI Braghiroli, LD Faria, G Bariani, A Alex, JEB Neto, ... Clinical colorectal cancer 15 (4), 321-328. e1, 2016 | 88 | 2016 |
| Diretriz BRASPEN de terapia nutricional no paciente com câncer LM Horie, APN Barrére, MG Castro, AMB Liviera, AMB Carvalho, ... BRASPEN J, 2019 | 80 | 2019 |
| Primary prevention of colorectal cancer: myth or reality? MC Teixeira, MI Braghiroli, J Sabbaga, PM Hoff World Journal of Gastroenterology: WJG 20 (41), 15060, 2014 | 76 | 2014 |
| An open-label, fixed-dose study of bupropion effect on sexual function scores in women treated for breast cancer C Mathias, CMC Mendes, EP de Sena, ED de Moraes, C Bastos, ... Annals of Oncology 17 (12), 1792-1796, 2006 | 65 | 2006 |
| Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma B Sangro, SL Chan, RK Kelley, G Lau, M Kudo, W Sukeepaisarnjaroen, ... Annals of Oncology 35 (5), 448-457, 2024 | 54 | 2024 |
| Phase II trial of metformin and paclitaxel for patients with gemcitabine-refractory advanced adenocarcinoma of the pancreas MI Braghiroli, ACR de Celis Ferrari, TE Pfiffer, AK Alex, D Nebuloni, ... Ecancermedicalscience 9, 2015 | 43 | 2015 |
| Dust mite species and allergen concentrations in beds of individuals belonging to different urban socioeconomic groups in Brazil T Baqueiro, FM Carvalho, CF Rios, NM Santos, MS Group, ... Journal of Asthma 43 (2), 101-105, 2006 | 42 | 2006 |
| Pembrolizumab with or without chemotherapy vs chemotherapy in patients with advanced G/GEJ cancer (GC) including outcomes according to Microsatellite Instability-High (MSI-H … K Shitara, E Van Cutsem, YJ Bang, CS Fuchs, L Wyrwicz, KW Lee, ... Annals of Oncology 30, v878-v879, 2019 | 39 | 2019 |
| Combination of irinotecan and a platinum agent for poorly differentiated neuroendocrine carcinomas R Ramella Munhoz, JF de Mendonça Rego, AR de Celis Ferrari, ... Rare tumors 5 (3), 135-139, 2013 | 36 | 2013 |
| Brazilian society of hepatology updated recommendations for diagnosis and treatment of hepatocellular carcinoma AL Chagas, AA MATTOS, FJ Carrilho, PL Bittencourt, ... Arquivos de Gastroenterologia 57 (suppl 1), 1-20, 2020 | 35 | 2020 |
| Pembrolizumab for metastatic adrenocortical carcinoma with high mutational burden: two case reports JM Mota, LG Sousa, MI Braghiroli, LT Siqueira, JEB Neto, P Chapchap, ... Medicine 97 (52), e13517, 2018 | 29 | 2018 |
| Academética: um novo método de estudo continuado sobre ética médica e bioética RA Athanazio, KM Lemos, DC Fonseca, MS Cunha, MIFM Braghiroli, ... Revista Brasileira de Educação Médica 28 (01), 73-78, 2004 | 29 | 2004 |
Paulo M. HoffProfessor de Oncologia, Faculdade de Medicina, Universidade de Sao PauloE-mail confirmado em icesp.org.br
